Mutations of the estrogen receptor in endometrial carcinoma: Evidence of an association with high tumor grade

Gynecologic Oncology

Volumn 63, Issue 2, 1996, Pages 192-199

  Assikis, Vasilios J ^a   Bilimoria, Malcolm M ^a   Muenzner, Henry D ^a   Lurain, John R ^a   Jordan, V Craig ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; ENDOMETRIUM CARCINOMA; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECEPTOR BINDING; SINGLE STRAND CONFORMATION POLYMORPHISM; TREATMENT OUTCOME;

EID: 0030297871     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0305     Document Type: Article

References (31)

1. 1. Osborne, C. K., Yochmowitz, M. G., Knight, W. A., and McGuire, W. L. The value of estrogen and progesterone receptors in the treatment of breast cancer, Cancer 46, 2884-2888 (1980).
2. 2. Runowicz, C. D., Nuchtern, L. M., Braunstein, J. D., and Jones, J. G. Heterogeneity in hormone receptor status in primary and metastatic endometrial cancer, Gynecol. Oncol. 38, 437-441 (1990).
3. 3. Kleine, W., Maier, T., Geyer, H., and Pfleiderer, A. Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance, Gynecol. Oncol. 38, 59-65 (1990).
4. 4. Kaupilla, A. Oestrogen and progestin receptors as prognostic indicators in endometrial cancer, Acta Oncol. 28, 561-566 (1989).
5. 5. Chambers, J. T., MacLusky, N., Eisenfield, A., Kohorn, E. I., Lawrence, R., and Schwartz, P. E. Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer, Gynecol. Oncol. 31, 65-77 (1988).
6. 6. Fuqua, S. A. W., Fitzgerald, S. D., Chamness, G. C., Tandon, A. K., McNonell, D. P., Nawaz, Z., O'Malley, B. W., and McGuire, W. L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity, Cancer Res. 51, 105-109 (1991).
7. 7. Zhang, Q-X., Borg, A., and Fuqua, S. A. W. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type receptor in human breast cancer, Cancer Res. 53, 5882-5884 (1993).
8. 8. Wang, Y., and Miksicek, R. J. Identification of a dominant negative form of the human estrogen receptor, Mol. Endocrinol. 5, 1707-1715 (1991).
9. 9. Wolf, D. N., and Jordan, V. C. The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain, Breast Cancer Res. Treat. 31, 129-138 (1994).
10. 10. Catherino, W. H., Wolf, D. M., and Jordan, V. C. A naturally occurring estrogen receptor mutation results in increased estrogenicity of tamoxifen analog, Mol. Endocrinol. 9, 1051-1063 (1995).
11. 11. Assikis, V. J., and Jordan, V. C. Gynecologic effects of tamoxifen and the association with endometrial carcinoma, Int. J. Gynecol. Obstet. 49, 241-257 (1995).
12. 12. Decensi, A., Fontana, V., Bruno, S., Gustavino, C., Gotteschi, B., and Costa, A. Effect of tamoxifen on endometrial proliferation. J. Clin. Oncol. 14, 434-440 (1996).
13. 13. Goldstein, S. R. Unusual ultrasound appearance of the uterus in patients receiving tamoxifen. Am. J. Obstet. Gynecol. 170, 447-451 (1994).
14. 14. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. A rapid and sensitive detection of point mutations and genetic polymorphisms using polymerase chain reaction, Genomics 5, 874-879 (1989).
15. 15. Announcements. FIGO stages - 1988 revisions, Gynecol. Oncol. 35, 125-126 (1989).
16. 16. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid-guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162, 156-159 (1987).
17. 17. Chung, C. T., and Miller, R. H. A rapid and convenient method for the preparation and storage of competent bacterial cells, Nucleic Acids Res. 16, 3580 (1988).
18. 18. Sanger, F. Determination of nucleotide sequences in DNA, Science 214, 1205-1210 (1981).
19. 19. Condie, A., Eeles, R., Borresen, A. L., Coles, C., Coopes, C., and Prosser, J. Detection of point mutations in the p53 gene: Comparison of single-strand conformational polymorphism, constant denaturant gel electrophoresis and hydroxyalanine and osmium tetroxide techniques, Hum. Mutat. 2, 58-66 (1993).
20. 20. Hayashi, K., and Yandell, D. W. How sensitive is PCR-SSCP? Hum. Mutat. 2, 338-346 (1993).
21. 21. Kohler, M. F., Berkholz, A., Risinger, J. I., Elbendary, A., Boyd, J., and Berchuck, A. Mutational analysis of the estrogen-receptor gene in endometrial carcinoma, Obstet. Gynecol. 86, 33-37 (1995).
22. 22. Keaveney, M., Klug, J., Dawson, M. T., Nestor, P. V., Neilan, J. G., Forde, R. C., and Gannon, F. Evidence for a previously unidentified upstream exon in the human oestrogen receptor gene, J. Mol. Endocrinol. 6, 111-115 (1991).
23. 23. Fujimoto, J., Hori, M., Ichigo, S., Misao, R., and Tamaya, T. Preliminary study of oncogene expressions in endometrial cancers: Aberrant estrogen receptor gene and erbB-2 expressions, Eur. J. Gynaec. Oncol. 16, 40-47 (1995).
24. CO cells genetically unstable and containing estrogen receptor mutations are a real model for the progression of breast cancers to hormone resistance, Cancer Res. 50, 6208-6217 (1990).
25. 25. Fuqua, S. A. W., Fitzgerald, S. D., Allred, D. C., Elledge, R. M., Nawaz, Z., McDonnell, D. P., O'Malley, B. W., Greene, G. L., and McGuire, W. L. Inhibition of estrogen receptor action by a naturally occuring variant in human breast tumors, Cancer Res. 52, 483-486 (1992).
26. 26. Lehrer, S., Sanchez, M., Song, H. K., Dalton, J., Levine, E., Savoretti, P., Thung, S. N., and Scachter, B. Oestrogen receptor B region polymorphism and spontaneous abortion in women with breast cancer, Lancet 335, 622-624 (1990).
27. 27. Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, T. C., Williams, D., Lubahn, B., and Korach, K. S. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man, N. Engl. J. Med. 331, 1056-1061 (1994).
28. 28. Karnik, P. S., Kulkarni, S., Liu, X. P., Budd, T., and Bukowski, R. M. Estrogen receptor mutations in tamoxifen-resistant breast cancer, Cancer Res. 54, 349-353 (1994).
29. 29. Struyer, L. Protein structure and function, in Biochemistry, Freeman, New York, pp. 15-43 (1988).
30. 30. Newmark, J. R., Hardy, D. O., Tonb, D. C., Carter, B. S., Epstein, J. I., Isaacs, W. B., Brown, T. R., and Barrack, E. R. Androgen receptor gene mutations in human prostate cancer, Proc. Natl. Acad. Sci. USA 89, 6319-6323 (1992).
31. 31. Leygue, E. R., Watson, P. H., and Murphy, L. C. Estrogen receptor variants in normal human tissue. J. Natl. Cancer Inst. 88, 284-290 (1996).